130 related articles for article (PubMed ID: 12366716)
21. Splenic lymphoma with circulating villous lymphocytes: report of seven cases and review of the literature.
Sun T; Susin M; Brody J; Dittmar K; Teichberg S; Weiner R; Lin JH; Felber N
Am J Hematol; 1994 Jan; 45(1):39-50. PubMed ID: 8250010
[TBL] [Abstract][Full Text] [Related]
22. Splenic marginal zone lymphoma with and without villous lymphocytes.
Matutes E
Curr Treat Options Oncol; 2007 Apr; 8(2):109-16. PubMed ID: 17680218
[TBL] [Abstract][Full Text] [Related]
23. [Successful treatment of splenic lymphoma with villous lymphocytes by rituximab and laparoscopic splenectomy].
Fujita T; Asagoe K; Sakoda H
Rinsho Ketsueki; 2003 Apr; 44(4):249-53. PubMed ID: 12784658
[TBL] [Abstract][Full Text] [Related]
24. Leptomeningeal involvement in a patient with splenic lymphoma with villous lymphocytes.
Gotlib V; Singareddy S; Gergis U; Vakios J; Guevara E; Chadburn A; Yavorkovsky LL; Patel A; Butt A; Nayak A
Leuk Lymphoma; 2002 Jun; 43(6):1337-40. PubMed ID: 12153005
[TBL] [Abstract][Full Text] [Related]
25. Splenic lymphoma with villous lymphocytes: case report and literature review.
Babadoko AA; Hassan A; Ahmed AJ; Isah HA; Suleiman AM
Niger J Med; 2007; 16(1):71-3. PubMed ID: 17563973
[TBL] [Abstract][Full Text] [Related]
26. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?
Saadoun D; Suarez F; Lefrere F; Valensi F; Mariette X; Aouba A; Besson C; Varet B; Troussard X; Cacoub P; Hermine O
Blood; 2005 Jan; 105(1):74-6. PubMed ID: 15353484
[TBL] [Abstract][Full Text] [Related]
27. [Splenic lymphoma with circulating villous lymphocytes].
Colović M; Janković G; Colović R; Mijović A; Antunović P
Srp Arh Celok Lek; 1994; 122(3-4):103-4. PubMed ID: 17972822
[TBL] [Abstract][Full Text] [Related]
28. Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphoma.
Keating MJ; McLaughlin P; Plunkett W; Robertson LE; O'Brien S; Gandhi V; Gregoire V; Yang L; Cabanillas F
Ann Oncol; 1994; 5 Suppl 2():79-83. PubMed ID: 8204523
[TBL] [Abstract][Full Text] [Related]
29. [Fludarabine treatment of chronic lymphoid leukemia].
Gabeeva NG; Pivnik AV; Moiseeva TN; Zybunova EE; Samoĭlova RS; Kremenetskaia AM; Varlamova EIu; Kaplanskaia IB
Ter Arkh; 2000; 72(8):42-5. PubMed ID: 11019427
[TBL] [Abstract][Full Text] [Related]
30. Circulating villous lymphocytes--a link between hyperreactive malarial splenomegaly and splenic lymphoma.
Bates I; Bedu-Addo G; Rutherford TR; Bevan DH
Trans R Soc Trop Med Hyg; 1997; 91(2):171-4. PubMed ID: 9196759
[TBL] [Abstract][Full Text] [Related]
31. [Experience with fludarabine treatment and review of the literature].
Telek B; Rejtó L; Kiss A; Batár P; Reményi G; Rák K; Udvardy M
Orv Hetil; 2002 Jun; 143(24):1459-65. PubMed ID: 12138643
[TBL] [Abstract][Full Text] [Related]
32. Splenic lymphoma with villous lymphocytes in tropical West Africa.
Bates I; Bedu-Addo G; Rutherford T; Bevan DH
Lancet; 1992 Sep; 340(8819):575-7. PubMed ID: 1355156
[TBL] [Abstract][Full Text] [Related]
33. Splenic lymphoma with villous lymphocytes should be included in the differential diagnosis of massive splenomegaly.
Bedu-Addo G; Rutheford T; Bevan D; Bates I
Croat Med J; 1998 Dec; 39(4):412-8. PubMed ID: 9841942
[TBL] [Abstract][Full Text] [Related]
34. p53 abnormalities in splenic lymphoma with villous lymphocytes.
Gruszka-Westwood AM; Hamoudi RA; Matutes E; Tuset E; Catovsky D
Blood; 2001 Jun; 97(11):3552-8. PubMed ID: 11369650
[TBL] [Abstract][Full Text] [Related]
35. Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma.
Zinzani PL; Magagnoli M; Moretti L; De Renzo A; Battista R; Zaccaria A; Guardigni L; Mazza P; Marra R; Ronconi F; Lauta VM; Bendandi M; Gherlinzoni F; Gentilini P; Ciccone F; Cellini C; Stefoni V; Ricciuti F; Gobbi M; Tura S
J Clin Oncol; 2000 Feb; 18(4):773-9. PubMed ID: 10673518
[TBL] [Abstract][Full Text] [Related]
36. Fludarabine and bendamustine in refractory and relapsed indolent lymphoma--a multicenter phase I/II Trial of the east german society of hematology and oncology (OSHO).
Koenigsmann M; Knauf W; Herold M; Pasold R; Müller G; Eschenburg H; Kahl C; Lakner V; Assmann M; Jentsch-Ullrich K; Mohren M; Bartsch R; Franke A
Leuk Lymphoma; 2004 Sep; 45(9):1821-7. PubMed ID: 15223642
[TBL] [Abstract][Full Text] [Related]
37. Splenic lymphoma with villus lymphocytes--an uncommon cause for lymphocytosis.
Kuperan P; Teo CP; Chong SM; Liu TC
Singapore Med J; 1997 Sep; 38(9):395-8. PubMed ID: 9407767
[TBL] [Abstract][Full Text] [Related]
38. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept.
Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J
Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628
[TBL] [Abstract][Full Text] [Related]
39. Splenic lymphoma with villous lymphocytes in two sisters.
Ribeiro I; Costa MM; Fernandes BA; Sousa I; Melo A; Parreira A; Uva LS
J Clin Pathol; 1992 Dec; 45(12):1111-3. PubMed ID: 1479039
[TBL] [Abstract][Full Text] [Related]
40. Intrasinusoidal bone marrow involvement by splenic lymphoma with villous lymphocytes: a helpful immunohistologic feature.
Labouyrie E; Marit G; Vial JP; Lacombe F; Fialon P; Bernard P; de Mascarel A; Merlio JP
Mod Pathol; 1997 Oct; 10(10):1015-20. PubMed ID: 9346181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
